Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAHALE benralizumab study in non-cystic fibrosis bronchiectasis
2020-004068-24Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis comparing Benralizumab with Placebo (2 arms). Primary endpoint: Annualized exacerbation rate estimated for the double-blind treatment period. Started Dec 2020; status: completed.
02
Drugs
benralizumab
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2020-004068-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004068-24.